Suppr超能文献

当被相同的生物碱激动剂激活时,δ和κ阿片受体通过发动蛋白依赖性内吞作用受到不同的调节。

Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist.

作者信息

Chu P, Murray S, Lissin D, von Zastrow M

机构信息

Nina Ireland Laboratory/Langley Porter Institute, University of California at San Francisco, San Francisco, California 94143, USA.

出版信息

J Biol Chem. 1997 Oct 24;272(43):27124-30. doi: 10.1074/jbc.272.43.27124.

Abstract

Many alkaloid drugs used as analgesics activate multiple opioid receptors. Mechanisms that distinguish the actions of these drugs on the regulation of individual micro, delta, and kappa receptors are not understood. We have observed that individual cloned opioid receptors differ significantly in their regulation by rapid endocytosis in the presence of alkaloid drug etorphine, a potent agonist of mu, delta, and kappa opioid receptors. Internalization of epitope-tagged delta opioid receptors from the plasma membrane is detectable within 10 min in the presence of etorphine. In contrast, kappa receptors expressed in the same cells remain in the plasma membrane and are not internalized for >/=60 min, even when cells are exposed to saturating concentrations of etorphine. The rapid internalization of delta receptors is specifically inhibited in cells expressing K44E mutant dynamin I, suggesting that type-specific internalization of opioid receptors is mediated by clathrin-coated pits. Examination of a series of chimeric mutant kappa/delta receptors indicates that at least two receptor domains, including the highly divergent carboxyl-terminal cytoplasmic tail, determine the type specificity of this endocytic mechanism. We conclude that structurally homologous opioid receptors are differentially sorted by clathrin-mediated endocytosis following activation by the same agonist ligand. These studies identify a fundamental mechanism of receptor regulation mediating type-specific effects of analgesic drugs that activate more than one type of opioid receptor.

摘要

许多用作镇痛药的生物碱药物会激活多种阿片受体。目前尚不清楚这些药物对单个μ、δ和κ受体调节作用的区分机制。我们观察到,在生物碱药物埃托啡(一种强效的μ、δ和κ阿片受体激动剂)存在的情况下,单个克隆的阿片受体在通过快速内吞作用进行调节方面存在显著差异。在埃托啡存在的情况下,10分钟内即可检测到表位标记的δ阿片受体从质膜内化。相比之下,即使细胞暴露于饱和浓度的埃托啡,在相同细胞中表达的κ受体仍保留在质膜中,并且在≥60分钟内不会内化。在表达K44E突变型发动蛋白I的细胞中,δ受体的快速内化受到特异性抑制,这表明阿片受体的类型特异性内化是由网格蛋白包被小窝介导的。对一系列嵌合突变κ/δ受体的研究表明,至少有两个受体结构域,包括高度不同的羧基末端细胞质尾巴,决定了这种内吞机制的类型特异性。我们得出结论,结构同源的阿片受体在被相同激动剂配体激活后,通过网格蛋白介导的内吞作用进行差异分选。这些研究确定了一种受体调节的基本机制,该机制介导了激活多种阿片受体的镇痛药的类型特异性效应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验